NUNN JASON RALEIGH enters ADDEX THERAPEUTICS LTD. with 219.56K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 3/18/2026ACC: 0001104659-26-030242
Director
Since Mar 2026
219.56K
Baseline shares
100% direct
219.56K
Direct ownership
1 position
50K
Derivative underlying
1 instrument
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned219.56K
Total
219.56K direct219.56K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 219.56K | Direct |
| Total | 219.56K | 219.56K direct |
Derivative Holdings1
Stock-option (Right to call)
DirectUnderlying security
Common Stock
Underlying shares
50K
Shares owned
N/A
Exercise price
0.064
Expiration
—
Exercise window
—
Total
Underlying
50K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock-option (Right to call) Direct | Common Stock | 0.064 | — | — | 50K | N/A |
| Total | 50K | 0.00 | ||||